Literature DB >> 29129574

Primary aldosteronism and cardiovascular risk, before and after treatment.

John W Funder1.   

Abstract

Mesh：

Substances：

Year:  2017        PMID： 29129574     DOI： 10.1016/S2213-8587(17)30368-6

Source DB:  PubMed          Journal:  Lancet Diabetes Endocrinol        ISSN： 2213-8587            Impact factor:   32.069


× No keyword cloud information.
  4 in total

1.  Case Report: Primary Aldosteronism and Subclinical Cushing Syndrome in a 49-Year-Old Woman With Hypertension Plus Hypokalaemia.

Authors:  Lihua Hu; Wenjun Ji; Tieci Yi; Jie Wang; Minghui Bao; Yusi Gao; Han Jin; Difei Lu; Wei Ma; Xiaoning Han; Jianping Li
Journal:  Front Cardiovasc Med       Date:  2022-05-30

2.  Urinary sodium potassium ratio is associated with clinical success after adrenalectomy in patients with unilateral primary aldosteronism.

Authors:  Ming-Jse Lee; Chiao-Yin Sun; Ching-Chu Lu; Yuan-Shian Chang; Heng-Chih Pan; Yen-Hung Lin; Vin-Cent Wu; Jeff S Chueh
Journal:  Ther Adv Chronic Dis       Date:  2021-02-12       Impact factor: 5.091

3.  Outcomes of Adrenalectomy and the Aldosteronoma Resolution Score in the Black and Hispanic Population.

Authors:  Gustavo Romero-Velez; Amanda M Laird; Manuel E Barajas; Mauricio Sierra-Salazar; Miguel F Herrera; Steven K Libutti; Michael K Parides; Xavier Pereira; John C McAuliffe
Journal:  World J Surg       Date:  2021-02-07       Impact factor: 3.352

4.  Tolerability and Efficacy of Long-Term Medical Therapy in Primary Aldosteronism.

Authors:  Fengjie Tang; Lih M Loh; Roger S Foo; Wann J Loh; Dawn S T Lim; Meifen Zhang; Pei T Tan; Du S Swee; Joan Khoo; Donovan Tay; Lynette Lee; Sarah Y Tan; Ling Zhu; Shui B Soh; Eberta Tan; Peng C Kek; Troy H Puar
Journal:  J Endocr Soc       Date:  2021-08-31
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.